Black Rock Inc. Black Diamond Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 1,380,522 shares of BDTX stock, worth $7.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,380,522

Previous 1,350,047 2.26%

Holding current value

$7.8 Million

Previous $3.79 Million 84.52%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$2.67 - $5.74 $81,368 - $174,926	30,475 Added 2.26%	1,380,522 $7 Million
Q4 2023 Feb 13, 2024	SELL	$1.77 - $3.03 $88,602 - $151,675	-50,058 Reduced 3.58%	1,350,047 $3.79 Million
Q3 2023 Nov 13, 2023	SELL	$2.87 - $4.99 $302,308 - $525,616	-105,334 Reduced 7.0%	1,400,105 $4.02 Million
Q2 2023 Aug 11, 2023	BUY	$1.43 - $6.18 $1.07 Million - $4.63 Million	749,052 Added 99.03%	1,505,439 $7.6 Million
Q1 2023 May 12, 2023	SELL	$1.35 - $3.14 $320,465 - $745,379	-237,382 Reduced 23.89%	756,387 $1.43 Million

Q4 2022 Feb 13, 2023	SELL	$1.28 - $2.51 $345,277 - $677,067	-269,748 Reduced 21.35%	993,769 $1.79 Million
Q3 2022 Nov 14, 2022	SELL	$1.96 - $4.01 $16,846 - $34,465	-8,595 Reduced 0.68%	1,263,517 $2.14 Million
Q2 2022 Aug 12, 2022	SELL	$1.5 - $3.63 $1.59 Million - $3.84 Million	-1,057,052 Reduced 45.38%	1,272,112 $3.13 Million
Q1 2022 May 12, 2022	BUY	$2.66 - $5.61 $214,654 - $452,710	80,697 Added 3.59%	2,329,164 $6.45 Million
Q4 2021 Feb 10, 2022	BUY	$5.18 - $8.48 $299,595 - $490,457	57,837 Added 2.64%	2,248,467 $12 Million
Q3 2021 Nov 09, 2021	BUY	$8.46 - $12.42 $308,096 - $452,311	36,418 Added 1.69%	2,190,630 $18.5 Million
Q2 2021 Aug 11, 2021	BUY	$12.19 - $28.17 $26.3 Million - $60.7 Million	2,154,212 New	2,154,212 $26.3 Million

Others Institutions Holding BDTX

# of Institutions

Shares Held

36.5M

Call Options Held

29.6K

Put Options Held

View Full List

About Black Diamond Therapeutics, Inc.

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $205M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

More about BDTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account